SANGAMO BIOSCIENCES

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SANGAMO BIOSCIENCES stocks are traded under the ticker GBY.

SANGAMO BIOSCIENCES is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

GBY earnings for the last quarter are −0.56 EUR per share, whereas the estimation was −0.30 EUR resulting in a −85.03% surprise. The estimated earnings for the next quarter are −0.23 EUR per share. See more details about SANGAMO BIOSCIENCES earnings.

SANGAMO BIOSCIENCES revenue for the last quarter amounts to ‪8.89 M‬ EUR despite the estimated figure of ‪8.85 M‬ EUR. In the next quarter revenue is expected to reach ‪7.34 M‬ EUR.

Yes, you can track SANGAMO BIOSCIENCES financials in yearly and quarterly reports right on TradingView.

No, GBY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GBY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANGAMO BIOSCIENCES stock right from TradingView charts — choose your broker and connect to your account.

GBY reached its all-time high on Mar 12, 2018 with the price of 21.9900 EUR, and its all-time low was 0.2700 EUR and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 28, 2024, the company has 405.00 employees. See our rating of the largest employees — is SANGAMO BIOSCIENCES on this list?

We've gathered analysts' opinions on SANGAMO BIOSCIENCES future price: according to them, GBY price has a max estimate of 7.36 EUR and a min estimate of 0.92 EUR. Read a more detailed SANGAMO BIOSCIENCES forecast: see what analysts think of SANGAMO BIOSCIENCES and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANGAMO BIOSCIENCES EBITDA is ‪−85.21 M‬ EUR, and current EBITDA margin is −52.26%. See more stats in SANGAMO BIOSCIENCES financial statements.